// OVERVIEW
Automated cell therapy development and manufacturing services via a global IDMO platform.
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
funding·Parsers VC·JUNE 16, 2026
“Raises $20M Series D Round from ARK Investment Management”
02
mention·Parsers VC·JUNE 16, 2026
“ARK Investment Management backing signals high-conviction bet on cell therapy manufacturing automation.”
03
mention·Parsers VC·JUNE 16, 2026
“Healthcare/biotech continues to attract sizable rounds (cell therapy, gene therapy, medtech), showing sustained capital flow into clinical and device plays.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.
// 06:00 ET DAILY · FREE
Track who’s shaping AI & tech.
Tomorrow’s 7 things from the AI & tech firehose, distilled, before your first meeting.
← BACK TO HOMEOne click unsubscribe